<DOC>
	<DOCNO>NCT00329173</DOCNO>
	<brief_summary>To compare reduction LDL-C safety 10mg rosuvastatin 20mg atorvastatin 6 week treatment</brief_summary>
	<brief_title>PULSAR - A Prospective Study Evaluate Utility Low Doses Statins Atorvastatin Rosuvastatin .</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Male female 18 . A history CHD clinical evidence atherosclerosis ( diabetic nondiabetic ) CHD risk equivalent ( 10year risk score &gt; 20 % CHD describe NCEP ATP III guidelines1 . History statin induce myopathy , serious hypersensitivity reaction HMGCoA reductase inhibitor ( statin ) , include rosuvastatin Pregnancy History homozygous familial hypercholesterolaemia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>